493 related articles for article (PubMed ID: 3095424)
1. Abrogation of hybrid resistance to bone marrow engraftment by graft-vs-host-induced immune deficiency.
Hakim FT; Shearer GM
J Immunol; 1986 Nov; 137(10):3109-16. PubMed ID: 3095424
[TBL] [Abstract][Full Text] [Related]
2. Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent-strain spleen cells. II. Evidence for an Hh-1 antigen-specific tolerization.
Kosmatopoulos K; Scott-Algara D; Halle-Pannenko O
J Immunol; 1988 Nov; 141(10):3285-92. PubMed ID: 2460528
[TBL] [Abstract][Full Text] [Related]
3. Role of L3T4+ and Lyt-2+ donor cells in graft-versus-host immune deficiency induced across a class I, class II, or whole H-2 difference.
Moser M; Sharrow SO; Shearer GM
J Immunol; 1988 Apr; 140(8):2600-8. PubMed ID: 3258615
[TBL] [Abstract][Full Text] [Related]
4. Loss of proliferative capacity and T cell immune development potential by bone marrow from mice undergoing a graft-vs-host reaction.
Iwasaki T; Fujiwara H; Iwasaki T; Shearer GM
J Immunol; 1986 Nov; 137(10):3100-8. PubMed ID: 2945856
[TBL] [Abstract][Full Text] [Related]
5. The target minor H antigen for F1 cytotoxic T lymphocytes induced by Igh-congenic parental spleen cells is coded for by gene linked to H-2.
Ishikawa H; Kubota E; Suzuki H; Saito K
J Immunol; 1985 May; 134(5):2953-9. PubMed ID: 2580009
[TBL] [Abstract][Full Text] [Related]
6. Modulation of F1 cytotoxic potentials by GvHR. Host- and donor-derived cytotoxic lymphocytes arise in the unirradiated F1 host spleens under the condition of GvHR-associated immunosuppression.
Kubota E; Ishikawa H; Saito K
J Immunol; 1983 Sep; 131(3):1142-8. PubMed ID: 6604089
[TBL] [Abstract][Full Text] [Related]
7. Modulation of F1 cytotoxic potentials by graft-vs-host reaction. Cooperative non-H-2- and H-2D region-gene control of F1 natural resistance to graft-vs-host reaction-associated immunosuppression.
Ishikawa H; Saito K; Kubota E
J Immunol; 1989 Mar; 142(5):1495-9. PubMed ID: 2918225
[TBL] [Abstract][Full Text] [Related]
8. Mutual recognition of parental and F1 lymphocytes. II. Analysis of graft-vs-host-induced suppressor cell activity for T cell-mediated lympholysis to trinitrophenyl self and alloantigens.
Polisson RP; Shearer GM
J Immunol; 1980 Oct; 125(4):1865-61. PubMed ID: 6967920
[TBL] [Abstract][Full Text] [Related]
9. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
Peres A; Nestel FP; Seemayer TA; Lapp WS
J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
[TBL] [Abstract][Full Text] [Related]
10. Microheterogeneity in regulatory circuits for T-cell alloresponsiveness.
Gorczynski RM; Macrae S
Immunology; 1981 Dec; 44(4):827-46. PubMed ID: 6172375
[TBL] [Abstract][Full Text] [Related]
11. Modulation of F1 cytotoxic potentials by GvHR: role and mode of action of non-MHC genes that determine the hybrid resistance to GvHR-associated suppression of F1 cytotoxic potential.
Ishikawa H; Kubota E; Saito K
J Immunol; 1984 May; 132(5):2218-25. PubMed ID: 6232314
[TBL] [Abstract][Full Text] [Related]
12. Non-H-2-linked genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. I. Non-H-2-linked Ir gene defect expressed on T cells is not predetermined at the stage of bone marrow cells.
Ogata M; Shimizu J; Tsuchida T; Takai Y; Fujiwara H; Hamaoka T
J Immunol; 1986 Feb; 136(4):1178-85. PubMed ID: 2935573
[TBL] [Abstract][Full Text] [Related]
13. Allosuppression of B cells in vitro by graft-vs.-host reaction-derived T cells is caused by cytotoxic T lymphocytes.
Rozendaal L; Pals ST; Schilham M; Melief CJ; Gleichmann E
Eur J Immunol; 1989 Sep; 19(9):1669-75. PubMed ID: 2792183
[TBL] [Abstract][Full Text] [Related]
14. Abrogation of bone marrow allograft resistance in mice by increased total body irradiation correlates with eradication of host clonable T cells and alloreactive cytotoxic precursors.
Schwartz E; Lapidot T; Gozes D; Singer TS; Reisner Y
J Immunol; 1987 Jan; 138(2):460-5. PubMed ID: 3098843
[TBL] [Abstract][Full Text] [Related]
15. Antigen-specific protection against graft-vs-host induced immune deficiency.
Iwasaki T; Hallam JA; Joseph LJ; Shearer GM
J Immunol; 1987 Jun; 138(11):3604-10. PubMed ID: 3035009
[TBL] [Abstract][Full Text] [Related]
16. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
[TBL] [Abstract][Full Text] [Related]
17. Lethal graft-vs-host disease induced by a class II MHC antigen only disparity is not mediated by cytotoxic T cells.
Thiele DL; Bryde SE; Lipsky PE
J Immunol; 1988 Nov; 141(10):3377-82. PubMed ID: 3053897
[TBL] [Abstract][Full Text] [Related]
18. Effect of graft-versus-host disease on anti-tumor immunity.
Schreiber KL; Forman J
J Immunol; 1990 Mar; 144(5):2018-26. PubMed ID: 1968493
[TBL] [Abstract][Full Text] [Related]
19. Immune dysfunction associated with graft-vs-host reaction in mice transplanted across minor histocompatibility barriers. II. Reversible defect in T-dependent antibody responses.
Budhecha S; Hamilton BL
J Immunol; 1989 Jun; 142(11):3740-5. PubMed ID: 2523932
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic T lymphocyte response to minor H-42a alloantigen in H-42b mice: clonal inactivation of the precursor cytotoxic T lymphocytes by veto-like spleen cells that express the H-42a antigen.
Ishikawa H; Hino T; Kato H; Suzuki H; Saito K
J Immunol; 1986 Oct; 137(7):2080-8. PubMed ID: 3489752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
